Inactive Instrument
Sector Charles River Laboratories International, Inc. Xetra
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 202.50 EUR | -6.18% |
|
-10.60% | - |
| 07-29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.46% | +3.76% | +1.07% | +18.66% | +5.73% | -0.59% | +12.55% | -20.41% | +213.80% | 49.37B | |
| -1.49% | +13.19% | +15.90% | +49.27% | +4.48% | +26.71% | +5.25% | -4.77% | +199.58% | 39.14B | |
| -2.21% | +0.32% | +1.24% | +36.11% | +138.34% | +409.36% | +623.20% | +547.03% | - | 40.85B | |
| -2.81% | -3.16% | +8.55% | +7.40% | +3.88% | +4.81% | +47.33% | -3.61% | +1,117.16% | 35.81B | |
| +5.56% | +11.70% | +6.03% | -2.21% | +10.22% | +11.64% | +51.50% | -11.63% | +159.73% | 30.5B | |
| -2.80% | -2.89% | -7.94% | +11.58% | - | - | - | - | - | 16.55B | |
| -1.11% | -4.22% | +5.97% | +37.96% | +2.56% | +34.84% | +127.53% | +228.11% | - | 16.14B | |
| -0.57% | -0.20% | -5.49% | +46.60% | -9.21% | -2.22% | -34.20% | -32.90% | +114.93% | 12.77B | |
| +0.26% | +3.58% | +0.47% | +18.87% | +10.22% | +2.17% | +9.91% | -32.12% | +102.98% | 13.71B | |
| +0.03% | +0.60% | +1.45% | +30.92% | +22.48% | +31.61% | -13.63% | -40.68% | +153.23% | 11.22B | |
| -1.01% | -4.79% | -8.60% | +7.29% | -10.80% | +67.81% | +513.01% | +267.18% | +2,439.01% | 10.77B | |
| -0.12% | -0.03% | +1.11% | +66.24% | +77.85% | +250.86% | +527.29% | - | - | 10.08B | |
| -3.25% | -7.67% | +24.47% | +22.86% | +26.66% | +11.90% | +37.29% | -59.07% | - | 8.9B | |
| -2.89% | -6.93% | -33.54% | -30.09% | -33.47% | +22.45% | +27.03% | +39.86% | +38.46% | 8.85B | |
| -4.24% | -5.36% | -8.37% | +29.65% | +34.48% | +139.18% | +378.24% | +75.54% | - | 8.8B | |
| -1.03% | -0.46% | +5.24% | +20.23% | -13.01% | -20.71% | -21.20% | -30.11% | +32.56% | 8.57B | |
| -4.40% | -1.18% | +7.46% | +36.74% | +54.01% | +149.74% | +593.35% | +174.06% | - | 8.92B | |
| -4.34% | -8.05% | -6.41% | -7.74% | +1.48% | +451.66% | +1,914.01% | +27.99% | - | 8.58B | |
| -2.42% | -6.58% | -4.47% | +48.02% | +76.59% | +86.52% | +68.75% | +83.41% | -0.30% | 8.39B | |
| Average | -1.53% | +1.54% | +0.22% | +23.60% | +22.36% | +93.21% | +270.40% | +71.05% | +415.56% | 18.31B | |
| Weighted average by Cap. | -1.12% | +4.48% | +2.64% | +23.88% | +26.60% | +89.73% | +205.21% | +89.13% | +413.42% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
